Furthermore, in vitro studies indicate that inhibition of ARG2 may even be beneficial for the anti-tumor T cell response (115, 169), whereas it may also directly inhibit the growth of ARG2-expressing tumors (170). The gene discussed is ARG2; the disease is neoplasm.